| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/08/2004 | WO2004003558A1 Nano-sized optical fluorescence labels and uses thereof |
| 01/08/2004 | WO2004003554A1 A method for the detection of apoptosis |
| 01/08/2004 | WO2004003539A1 Method of analyzing substance on substrate by mass spectrometry |
| 01/08/2004 | WO2004003513A2 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 01/08/2004 | WO2004003512A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | WO2004003511A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | WO2004003509A2 A method to identify specific interaction between ligand and receptor |
| 01/08/2004 | WO2004003234A2 A system and method for snp genotype clustering |
| 01/08/2004 | WO2004003233A1 Methods to assess quality of microarrays |
| 01/08/2004 | WO2004003231A2 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 01/08/2004 | WO2004003218A2 Antisense modulation of hypothetical protein loc51249 expression |
| 01/08/2004 | WO2004003217A1 Glutathione production |
| 01/08/2004 | WO2004003209A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | WO2004003208A2 Stress tolerant plant |
| 01/08/2004 | WO2004003207A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | WO2004003206A1 Novel transglucuronidases and genes tehreof |
| 01/08/2004 | WO2004003205A1 Hansenula polymorpha mutant strains with defect in outer chain biosynthesis and the production of recombinant glycoproteins using the same strains |
| 01/08/2004 | WO2004003204A1 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same |
| 01/08/2004 | WO2004003203A1 Human cervical cancer 5 protooncogene and protein encoded therein |
| 01/08/2004 | WO2004003202A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 01/08/2004 | WO2004003201A2 Antisense modulation of lrh1 expression |
| 01/08/2004 | WO2004003200A1 Isolation of nucleic acids using a polycationic polymer as precipitation agent |
| 01/08/2004 | WO2004003199A1 Novel method of acquiring nucleic acid or gene |
| 01/08/2004 | WO2004003198A1 Method of examining allergic disease and drug for treating the same |
| 01/08/2004 | WO2004003197A1 Yeast-origin promoter and vector and expression system using the same |
| 01/08/2004 | WO2004003196A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT |
| 01/08/2004 | WO2004003195A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | WO2004003194A2 Protein glycosylation modification in pichia pastoris |
| 01/08/2004 | WO2004003191A1 Regulation of human map kinase kinase kinase |
| 01/08/2004 | WO2004003189A2 Regulation of human phospholipase c-like protein |
| 01/08/2004 | WO2004003186A2 Subtilases and subtilase variants having altered immunogenicity |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003180A1 Method of controlling gene silencing using site-specific recombination |
| 01/08/2004 | WO2004003177A2 Use of regulatory sequences in transgenic plants |
| 01/08/2004 | WO2004003176A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 01/08/2004 | WO2004003175A2 Process and materials for production of glucosamine and n-acetylglucosamine |
| 01/08/2004 | WO2004003169A2 Recombinant genes for polyketide modifying enzymes |
| 01/08/2004 | WO2004003166A2 Antibodies and uses thereof |
| 01/08/2004 | WO2004003157A2 Gene regulation in transgenic animals using a transposon-based vector |
| 01/08/2004 | WO2004003156A2 Il-21 as a regulator of immunoglobin production |
| 01/08/2004 | WO2004003153A2 Live replicating spumavirus vector |
| 01/08/2004 | WO2004003152A2 Sos1 inhibitors |
| 01/08/2004 | WO2004003148A2 Genes encoding proteins with pesticidal activity |
| 01/08/2004 | WO2004003146A2 Method for improving plant traits by altering the activity of plant g-protein alpha and beta subunits |
| 01/08/2004 | WO2004003139A2 Modified shine-dalgarno sequences and methods of use thereof |
| 01/08/2004 | WO2004003136A2 Methods of detecting sequence differences |
| 01/08/2004 | WO2004003135A2 Selective cloning of homoduplex nucleic acids |
| 01/08/2004 | WO2004003134A2 Antisense inhibition via rnase h-independent reduction in mrna |
| 01/08/2004 | WO2004003133A1 Pain signaling molecules |
| 01/08/2004 | WO2004003021A1 HUMAN IgM ANTIBODY INDUCING APOPTOSIS IN HIV-INFECTED CELLS AND REMEDY FOR HIV-INFECTION |
| 01/08/2004 | WO2004003019A2 Immunoglobin single variant antigen-binding domains and dual-specific constructs |
| 01/08/2004 | WO2004003016A2 Marked peptides having affinity for a phospholipid and uses |
| 01/08/2004 | WO2004003015A2 Peptides having affinity for a phospholipid and uses |
| 01/08/2004 | WO2004003014A2 Gene for increased somatic recombination |
| 01/08/2004 | WO2004003013A1 Gene for increased somatic recombination |
| 01/08/2004 | WO2004003012A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | WO2004003009A2 Francisella tularensis immunogenic proteins and dna encoding these |
| 01/08/2004 | WO2004003006A2 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods |
| 01/08/2004 | WO2004002535A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 01/08/2004 | WO2004002459A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 01/08/2004 | WO2004002431A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002416A2 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2004002216A2 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof |
| 01/08/2004 | WO2004002215A2 Genetic manipulation of condensed tannins |
| 01/08/2004 | WO2004002214A2 Tagetes erecta marigolds with altered carotenoid compositions and ratios |
| 01/08/2004 | WO2003093455A3 Adenovirus vectors for immunotherapy |
| 01/08/2004 | WO2003092579A3 Compositions and methods for treating cancer with an oncolytic viral agent |
| 01/08/2004 | WO2003091408A3 Characterization of single stranded nucleic acids by melting analysis using a double strand specific nucleic acid dye |
| 01/08/2004 | WO2003091387A3 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 01/08/2004 | WO2003089640A3 Biofertilizer for plants based on rhizobium bacteria having an improved nitrogen fixing capacity |
| 01/08/2004 | WO2003087397A3 Process control based on microbiological activity |
| 01/08/2004 | WO2003085090A3 A human ribonucleotide reductase m2 subunit |
| 01/08/2004 | WO2003080839A3 Antigen fragments for the diagnosis of toxoplasma gondii |
| 01/08/2004 | WO2003080665A3 Antibody that binds to a dimer of a prion protein for the treatment of tse infection |
| 01/08/2004 | WO2003078625A3 An improved method for synthesising templated molecules |
| 01/08/2004 | WO2003078614A3 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants |
| 01/08/2004 | WO2003077643A3 Methods for increasing the oil content in plants by reducing the content of one or more storage proteins |
| 01/08/2004 | WO2003076949A3 Tagging and recovery of elements associated with target molecules |
| 01/08/2004 | WO2003075844A3 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 01/08/2004 | WO2003074731A3 Nucleic acid probes, their synthesis and use |
| 01/08/2004 | WO2003072051A3 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 01/08/2004 | WO2003070969A3 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/08/2004 | WO2003070875A3 Container with at least one electrode |
| 01/08/2004 | WO2003068928A3 Gene function inferring using gene expression data |
| 01/08/2004 | WO2003068812A3 Immune-modulating peptide made of s. aureus enterotoxin b |
| 01/08/2004 | WO2003067262A3 Methods and compositions involving the hsp90 activator aha1 |
| 01/08/2004 | WO2003063766A3 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/08/2004 | WO2003060655A3 INTERACTIONS OF CONNECTRONS, INTERFERENCE RNAs AND SMALL TEMPORAL RNAs IN PROKARYOTIC, ARCHEA AND EUKARYOTIC GENOMES |
| 01/08/2004 | WO2003057915A3 Methods of detecting hcv genotype 1 (hcv-1) by using primers specific for the 5’ non-coding region (ncr) of the hcv genome |
| 01/08/2004 | WO2003054194A3 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 01/08/2004 | WO2003050238A3 Receptor-targeted adenoviral vectors |
| 01/08/2004 | WO2003045965A3 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 01/08/2004 | WO2003043648A3 Sfcyr iib or sfcyr iii for the treatment of auto-immune diseases |
| 01/08/2004 | WO2003035895A3 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| 01/08/2004 | WO2003031570A3 METHOD FOR CLONING AND EXPRESSION OF BseRI RESTRICTION ENDONUCLEASE AND BseRI METHYLASE IN E. COLI |
| 01/08/2004 | WO2003027313A3 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| 01/08/2004 | WO2003025169A3 Nucleic acid for cloning vector |
| 01/08/2004 | WO2003020897A3 Compositions and methods relating to ovary specific genes and proteins |